Current multidisciplinary oncology series

di Sebio, Ana, Lenz, Heinz-Josef
Pubblicazione 2014

Molecular Pathways: Hippo Signaling, a Critical Tumor Suppressor

di Sebio, Ana, Lenz, Heinz-Josef
Pubblicato in Clin Cancer Res (2015)

Relevance of CYP3A4*20, UGT1A1*37 and UGT1A1*28 variants in irinotecan‐induced severe toxicity

di Riera, Pau, Salazar, Juliana, Virgili, Anna C., Tobeña, María, Sebio, Ana, Gallano, Pía, Barnadas, Agustí, Páez, David
Pubblicato in Br J Clin Pharmacol (2018)

ABCB1 Genetic Variants as Predictors of Irinotecan-Induced Severe Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients

di Riera, Pau, Artigas-Baleri, Alícia, Salazar, Juliana, Sebio, Ana, Virgili, Anna C., Arranz, María Jesús, Páez, David
Pubblicato in Front Pharmacol (2020)

Pharmacogenetic clinical randomised phase II trial to evaluate the efficacy and safety of FOLFIRI with high-dose irinotecan (HD-FOLFIRI) in metastatic colorectal cancer patients ac...

di Páez, David, Tobeña, María, Fernández-Plana, Julen, Sebio, Ana, Virgili, Anna C., Cirera, Lluís, Barnadas, Agustí, Riera, Pau, Sullivan, Ivana, Salazar, Juliana
Pubblicato in Br J Cancer (2018)

Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs

di Nogales, Vanesa, Reinhold, William C., Varma, Sudhir, Martinez-Cardus, Anna, Moutinho, Catia, Moran, Sebastian, Heyn, Holger, Sebio, Ana, Barnadas, Agusti, Pommier, Yves, Esteller, Manel
Pubblicato in Oncotarget (2015)

Germline polymorphisms in genes involved in the Hippo pathway as recurrence biomarkers in stage II/III colon cancer

di Sebio, Ana, Matsusaka, Satoshi, Zhang, Wu, Yang, Dongyun, Ning, Yan, Stremitzer, Stefan, Stintzing, Sebastian, Sunakawa, Yu, Yamauchi, Shinichi, Fujimoto, Yoshiya, Ueno, Masashi, Lenz, Heinz-Josef
Pubblicato in Pharmacogenomics J (2015)

Genetic variants within obesity-related genes are associated with tumor recurrence in patients with stages II/III colon cancer

di Sebio, Ana, Gerger, Armin, Matsusaka, Satoshi, Yang, Dongyun, Zhang, Wu, Stremitzer, Stefan, Stintizing, Sebastian, Sunakawa, Yu, Yamauchi, Shinichi, Ning, Yan, Fujimoto, Yoshiya, Ueno, Masashi, Lenz, Heinz-Josef
Pubblicato in Pharmacogenet Genomics (2015)

Novel Somatic Genetic Variants as Predictors of Resistance to EGFR-Targeted Therapies in Metastatic Colorectal Cancer Patients

di Riera, Pau, Rodríguez-Santiago, Benjamín, Lasa, Adriana, Gonzalez-Quereda, Lidia, Martín, Berta, Salazar, Juliana, Sebio, Ana, Virgili, Anna C., Minguillón, Jordi, Camps, Cristina, Surrallés, Jordi, Páez, David
Pubblicato in Cancers (Basel) (2020)

Genetic variations in angiopoietin and pericyte pathways and clinical outcome in patients with resected colorectal liver metastases

di Stremitzer, Stefan, Zhang, Wu, Yang, Dongyun, Ning, Yan, Stintzing, Sebastian, Sebio, Ana, Sunakawa, Yu, Yamauchi, Shinichi, Matsusaka, Satoshi, El-Khoueiry, Rita, Stift, Judith, Wrba, Friedrich, Gruenberger, Thomas, Lenz, Heinz-Josef
Pubblicato in Cancer (2015)

A Novel NFIX-STAT6 Gene Fusion in Solitary Fibrous Tumor: A Case Report

di Moura, David S., Díaz-Martín, Juan, Bagué, Silvia, Orellana-Fernandez, Ruth, Sebio, Ana, Mondaza-Hernandez, Jose L., Salguero-Aranda, Carmen, Rojo, Federico, Hindi, Nadia, Fletcher, Christopher D. M., Martin-Broto, Javier
Pubblicato in Int J Mol Sci (2021)

TWIST1 polymorphisms predict survival in patients with metastatic colorectal cancer receiving first-line bevacizumab plus oxaliplatin-based chemotherapy

di Matsusaka, Satoshi, Zhang, Wu, Cao, Shu, Hanna, Diana L., Sunakawa, Yu, Sebio, Ana, Ueno, Masashi, Yang, Dongyun, Ning, Yan, Parekh, Anish, Okazaki, Satoshi, Berger, Martin D., Ichikawa, Wataru, Mizunuma, Nobuyuki, Lenz, Heinz-Josef.
Pubblicato in Mol Cancer Ther (2016)

Prognostic impact of c-MET polymorphism on clinical outcome in loco-regional gastric cancer patients

di Sunakawa, Yu, Wakatsuki, Takeru, Yang, Dongyun, Zhang, Wu, Ning, Yan, Stintzing, Sebastian, Stremitzer, Stefan, Yamauchi, Shinichi, Sebio, Ana, El-khoueiry, Rita, Iqbal, Syma, Afsaneh, Barzi, Gerger, Armin, Stotz, Michael, Azuma, Mizutomo, Watanabe, Masahiko, Koizumi, Wasaburo, Lenz, Heinz-Josef
Pubblicato in Pharmacogenet Genomics (2014)

Polymorphisms in genes involved in EGFR-turnover are predictive for cetuximab efficacy in colorectal cancer

di Stintzing, Sebastian, Zhang, Wu, Heinemann, Volker, Neureiter, Daniel, Kemmerling, Ralf, Kirchner, Thomas, Jung, Andreas, Folwaczny, Matthias, Yang, Dongyun, Ning, Yan, Sebio, Ana, Stremitzer, Stefan, Sunakawa, Yu, Matsusaka, Satoshi, Yamauchi, Shinichi, Loupakis, Fotios, Cremolini, Chiara, Falcone, Alfredo, Lenz, Heinz-Josef
Pubblicato in Mol Cancer Ther (2015)

Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors

di Serrano, César, Vivancos, Ana, López-Pousa, Antonio, Matito, Judit, Mancuso, Francesco M., Valverde, Claudia, Quiroga, Sergi, Landolfi, Stefania, Castro, Sandra, Dopazo, Cristina, Sebio, Ana, Virgili, Anna C., Menso, María M., Martín-Broto, Javier, Sansó, Miriam, García-Valverde, Alfonso, Rosell, Jordi, Fletcher, Jonathan A., George, Suzanne, Carles, Joan, Arribas, Joaquín
Pubblicato in BMC Cancer (2020)

Clinicopathological and Molecular Characterization of Metastatic Gastrointestinal Stromal Tumors with Prolonged Benefit to Frontline Imatinib

di Serrano, César, García‐del‐Muro, Xavier, Valverde, Claudia, Sebio, Ana, Durán, José, Manzano, Aránzazu, Pajares, Isabel, Hindi, Nadia, Landolfi, Stefania, Jiménez, Laura, Rubió‐Casadevall, Jordi, Estival, Anna, Lavernia, Javier, Safont, María José, Pericay, Carles, Díaz‐Beveridge, Roberto, Martínez‐Marín, Virginia, Vicente‐Baz, David, Vivancos, Ana, Hernández‐Losa, Javier, Arribas, Joaquín, Carles, Joan
Pubblicato in Oncologist (2018)